treatment of idiopathic pulmonary fibrosis
All entries for: PureTech LYT 100, Inc., a subsidiary of PureTech Health plc
February 19, 2026
PureTech LYT 100, Inc., a subsidiary of PureTech Health plc
Orphan Drug Designation
Boston
1-50 employees
Disease Area: Rare Disease